Non-CME/CE
Rare Diseases
This program will examine:
1) Uncontrolled gout as chronic, systemic, and highly comorbid with a range of diseases, 2) An effective treatment option with a proven safety profile and over 13 years of real-world experience, and 3) Best practices for referring patients early in the course of disease
Amgen, Inc.